Art

J-GLOBAL ID：201202291740206860   Reference number：12A0870321

Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): A randomised, open-label, blinded-endpoints trial

重篤な川崎病の冠状動脈異常予防のための免疫グロブリン併用プレドニゾロンの効果(RAISE試験):無作為化オープンラベル盲検化エンドポイント試験

Author (23)： KOBAYASHI Tohru (Gunma Univ. Graduate School of Medicine, Gunma, JPN) ,  ARAKAWA Hirokazu (Gunma Univ. Graduate School of Medicine, Gunma, JPN) ,  MORIKAWA Akihiro (Gunma Univ. Graduate School of Medicine, Gunma, JPN) ,  SAJI Tsutomu (Toho Univ. Omori Medical Center, Tokyo, JPN) ,  TAKATSUKI Shinichi (Toho Univ. Omori Medical Center, Tokyo, JPN) ,  OTANI Tetsuya (National Center for Child Health and Dev., Tokyo, JPN) ,  TAKEUCHI Kazuo (Saitama Univ., Saitama, JPN) ,  NAKAMURA Tetsuya (Gunma Univ. Hospital, Gunma, JPN) ,  KATO Taichi (Nagoya Univ. Graduate School of Medicine, Nagoya, JPN) ,  HARA Toshiro (Kyusyu Univ., Fukuoka, JPN) ,  HAMAOKA Kenji (Kyoto Prefectural Univ. Medicine, Kyoto, JPN) ,  OGAWA Shunichi (Nippon Medical School, Tokyo, JPN) ,  FUKAZAWA Ryuji (Nippon Medical School, Tokyo, JPN) ,  MIURA Masaru (Tokyo Metropolitan Children’s Medical Center, Tokyo, JPN) ,  NOMURA Yuichi (Kagoshima Univ., Kagoshima, JPN) ,  FUSE Shigeto (NTT East Japan Sapporo Hospital, Sapporo, JPN) ,  ICHIDA Fukiko (Toyama Univ., Toyama, JPN) ,  SEKI Mitsuru (Gunma Children’s Medical Center, Gunma, JPN) ,  FUKAZAWA Ryuji (Nippon Medical School Tama Nagayama Hospital, Tokyo, JPN) ,  OGAWA Chitose (St Luke’s International Hospital, Tokyo, JPN) ,  FURUNO Kenji (Fukuoka Higashi Medical Center, Fukuoka, JPN) ,  TOKUNAGA Hirohide (Nagoya Memorial Hospital, Nagoya, JPN) ,  HARA Shinya (Toyota Memorial Hospital, Toyota, JPN)
Material： Lancet
Volume： 379  Issue： 9826  Page： 1613-1620  Publication year： Apr. 2012 
JST Material Number： B0673A  ISSN： 0140-6736  CODEN： LANCA  Document type： Article
Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Terms in the title (10)： 川崎病 ,  冠状動脈 ,  予防 ,  免疫グロブリン ,  併用 ,  プレドニゾロン ,  試験 ,  ラベル ,  盲 ,  エンドポイント